
Hereditary Plasma Clotting Factor Disorders and their Management
This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Russian This monograph
Year: 2018
Language: Traditional Chinese
Author(s): Jenny Goudemand, Manuel Carcao
Format: Document
Also Available In: English, Spanish
This is not an official WFH translation. This resource has been translated with permission by a WFH National Member Organization (NMO), and is shared here with their kind permission. Translating organizations are encouraged to have translations reviewed by local experts, the WFH is not responsible for the translation or for any errors or changes to content from the original English edition. Patient organizations interested in translating a WFH resource must first obtain permission from the WFH, available here.
Inhibitors are a serious complication of hemophilia caused by an immune response to clotting factor concentrates. Treatment of inhibitors is one of the biggest challenges in hemophilia care today. This primer explains our current understanding of how and why inhibitors form, reviews the established approaches to managing inhibitors, and looks ahead to some potential future developments in the field.

This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Russian This monograph

Also Available In: English, Spanish This is not an official WFH translation. This resource has been translated with permission by

People with hemophilia are at risk for severe bleeding that may require emergency care. This monograph discusses a number of

The purpose of these guidelines is to provide a basis for the development of local protocols for the dental treatment

A quick overview of the epidemiology, diagnosis, and treatment of each of the rare factor deficiencies.

Highlights the various options available when treatment products are extremely scarce. Even with a limited amount of coagulation factor, it